Your doctor prescribed Nurtec ODT because it's the right treatment for your migraines. Your insurer said no. But you don't have to just give up on Nurtec. If it's the right treatment for you, let's talk about how to get covered.

Nurtec ODT is the only oral CGRP medication approved by the FDA for both treating acute migraines and preventing them. That dual role is a genuine clinical advantage, and it's precisely what makes the insurance process so frustrating. Insurers may apply different criteria depending on whether your doctor prescribed Nurtec for acute use, preventive use, or both, and many patients (and even some prescribers) don't realize the way the prescription is written directly determines which criteria the insurer evaluates.

Here's what Pfizer's own data says: 97% of patients with commercial insurance have plans that cover Nurtec ODT. If you were denied, that means that there's likely a path to getting covered through an appeal — whether it's through demonstrating that you meet the criteria, updating paperwork, or proving you deserve an exception to their rules.

If you're denied Nurtec, you can appeal

Fewer than 1% of denied claims are ever appealed. Insurance companies count on that. But when patients do appeal with the right evidence, they often win. At Claimable, we see this in practice — with over 80% of our appeals getting approved in established conditions.

This guide walks you through exactly why your Nurtec coverage was denied, how to identify your specific denial type, and what a winning appeal actually looks like, including the timelines, documentation, and strategies that work.

Why Insurance Companies Deny Nurtec Coverage

Understanding the specific reason for your denial is the single most important step before doing anything else. The denial reason determines your entire strategy, and getting it wrong means wasting time on arguments that won't work for your situation.

What Makes Nurtec Denials Uniquely Complicated

Most migraine medications do one thing: treat an attack or prevent future ones. Nurtec does both. That's a significant clinical advantage, but it creates a coverage problem that doesn't exist with drugs like Ubrelvy (acute only) or Qulipta (prevention only).

If your doctor prescribed Nurtec for acute use, the insurer applies one set of criteria, typically requiring you to have tried and failed triptans first. If prescribed for prevention (every-other-day dosing), the insurer applies a different, often stricter set of criteria — requiring documented failure of older preventive drugs like beta-blockers, antidepressants, or antiepileptics.

If your doctor intended Nurtec to serve both roles, the prior authorization may need to address both sets of requirements simultaneously. Many prescribers don't realize this, and many PAs are submitted addressing only one indication.

The quantity of tablets prescribed can also trigger a denial. Preventive dosing requires roughly 15 tablets per month, while acute use calls for up to 8. A prescription for 15 tablets submitted with acute-only documentation will get flagged immediately.

The mismatch between how the prescription is written and what the insurer's criteria require is one of the most common, and most preventable, reasons Nurtec gets denied.

The Most Common Types of Nurtec Denials

Most articles list denial types using the language insurers put in their letters. We think about denial types based on what they actually mean for patients and how they shape your strategy.

Step Therapy Required

This is the most common Nurtec denial. Insurers require patients to try and fail older medications first — especially triptans — before approving Nurtec, even when your doctor has clinical reasons for prescribing it first.

For acute use, most plans require documented failure of two or more triptans (sumatriptan, rizatriptan, zolmitriptan, eletriptan). For preventive use, the bar is even higher — many plans require failure of medications from two or more drug classes: beta-blockers (propranolol, metoprolol), antidepressants (amitriptyline, venlafaxine), antiepileptics (topiramate, valproate), or other CGRP therapies.

What most patients don't realize: "Failure" doesn't mean the drug didn't work. Side effects, contraindications, and medical reasons a drug is inappropriate also count as failure. For example, many patients with cardiovascular disease can't safely take triptans, which means insurers should not require them to try these medications first.

Important: The American Headache Society's 2024 position statement explicitly recommends CGRP-targeting therapies — including Nurtec — as a first-line option for migraine prevention, without requiring prior failure of older drug classes. When an insurer demands you fail on beta-blockers or topiramate before accessing Nurtec, they're contradicting the leading medical society's guidance. That's a powerful argument in any appeal.

Not Medically Necessary

This denial often means the initial submission was too thin, not that your insurer reviewed your full history and determined Nurtec isn't appropriate. Common gaps: not specifying migraine frequency, not listing comorbidities, not documenting impact on daily functioning, or not explaining why Nurtec specifically is the right choice.

A Nurtec watch-out: Because the drug is approved for both acute and preventive use, the prescriber needs to clearly document which indication is being requested and why. A submission that doesn't specify this can trigger a medical necessity denial even when you need it.

Quantity Limit Exceeded

Many insurers set a default quantity limit of 8 tablets per month, aligned with acute use. If your doctor prescribed Nurtec for prevention (roughly 15 tablets per month), the prescription may automatically get flagged.

This is often a straightforward fix: your prescriber submits documentation confirming the preventive indication and requests a quantity override. But the quantity limit PA criteria are often separate from the initial coverage PA, so you may need to clear two hurdles, not one.

Not on Formulary / Non-Preferred Brand

Some plans prefer a different CGRP medication — often Ubrelvy for acute use, or Qulipta, Aimovig, Emgality, or Ajovy for prevention. This isn't a medical judgment about whether you need the medication, it's a business decision about which drugs the insurer has negotiated pricing for.

The strongest argument centers on Nurtec's dual indication. If your doctor prescribed it for both acute treatment and prevention — which no other oral CGRP medication can do — replacing it with two separate drugs increases complexity, cost, and adherence burden. That's a compelling case for a formulary exception.

PA Requirements Not Met

This denial means the insurer believes one or more coverage criteria weren't satisfied. In many cases, the issue isn't that you actually fail the criteria — it's that the insurer applied the rules incorrectly, ignored clinical details, or relied on outdated requirements.

Common scenarios: migraine frequency disputes (your documented frequency meets the threshold but wasn't clearly presented), indication mismatch (the PA was submitted for one indication but the quantity suggests another), or incomplete treatment history (the documentation didn't fully capture your prior medication trials).

Incorrect Diagnosis Code

Coverage often hinges on submitting the correct ICD-10 diagnosis code. Common issues include using a general headache code instead of a specific migraine code, or failing to specify episodic migraine when requesting preventive coverage. Pfizer's own resources flag incorrect codes as one of the most common reasons for Nurtec PA denials. This is often the easiest denial to fix.

A breakdown of common ICD-10 diagnosis codes for migraine treatment:

Duplicate CGRP Therapy Denial

If you're already taking an injectable CGRP (Aimovig, Ajovy, or Emgality) for prevention, some insurers will deny Nurtec for acute use, claiming you can't use two CGRP drugs at the same time. This denial is often wrong — the American Headache Society and published clinical evidence support using a CGRP monoclonal antibody for prevention alongside an oral gepant for acute treatment, because they work through different mechanisms. Overturning this typically requires a detailed clinical rationale from a neurologist or headache specialist.

How to Appeal a Nurtec Denial: Step by Step

Appeals work far more often than most people think. The insurance industry has spent decades conditioning patients to accept "no" as final. It's not.

Step 1: Read Your Denial Letter Carefully

Your denial letter is required by law to include the specific reason for denial, your appeal rights, and the deadline to file.

Find your deadline. Most commercial plans allow 180 days, but deadlines vary significantly by insurer. UnitedHealthcare gives you just 65 days for most plan types — less than half the time Aetna, BCBS, and Cigna allow. Medicare Advantage plans follow CMS guidelines of 60 days. Missing the deadline means you won't be allowed to appeal, so move as quickly as possible.

Step 2: Understand That You Can Appeal, Not Just Your Doctor

You can file an appeal yourself, as the patient, separate from (or in addition to) your doctor filing a provider-level appeal. Patient-initiated appeals often have stronger legal protections than provider appeals — including mandated response timelines, the right to escalate to an independent external reviewer, and multiple levels of appeal. If your doctor's prior authorization or appeal was denied, that doesn't mean yours will be. They're different processes.

Step 3: Clarify the Prescription With Your Doctor

Before gathering documentation, confirm with your prescriber: Was Nurtec prescribed for acute treatment, preventive treatment, or both? Was the PA submitted with the correct indication and quantity? Were the correct ICD-10 migraine codes used?

If the issue is a mismatch between the prescription and the PA submission, a corrected resubmission may resolve the denial without a formal appeal.

Step 4: Get a Letter of Medical Necessity

A letter of medical necessity (LOMN) from your prescribing physician is the single most important document in a Nurtec appeal. It should include documentation of your migraine days per month, prior medication history and diagnosis code.

How to ask your doctor: Be direct. "My insurance denied Nurtec. Would you be willing to write a letter of medical necessity for my appeal? I can bring information on what the insurer typically looks for." Some doctors aren't experienced with writing these, but offering a template or outline can help significantly.

Step 5: Build Your Appeal Package

Your appeal should include a cover letter summarizing your case, the letter of medical necessity from your doctor, supporting clinical documentation (records showing migraine frequency, treatment history, comorbidities), and a personal statement explaining how the denial affects your health and daily life.

The three pillars of a winning appeal:

1. Your story — the personal health impact of this denial
2. Clinical evidence — studies, guidelines, and medical records supporting Nurtec for your situation
3. Policy and legal analysis — how your situation meets coverage criteria under your plan, state law, and federal regulations

Step 6: Submit and Track

Submit your appeal per the instructions in your denial letter. Your insurer is required to respond within 30 days for standard appeals, or 72 hours for urgent/expedited cases. Keep records of when you submitted, how (fax, mail, portal), and any confirmation numbers.

Step 7: Escalate If Needed

If your internal appeal is denied, you have the right to an external review by an independent third party not employed by the insurer. External reviews commonly overturn denials that make it to that stage — because the reviewer evaluates whether the denial was medically justified, not whether the insurer wants to pay.

Don't give up after one "no." The system is designed to make you quit. Persistence is part of the strategy.

An Easier Path: Let Claimable Handle Your Nurtec Appeal

If navigating this process feels overwhelming, or if you just don't have time to become an expert in insurance appeals, Claimable can help.

Here's how it works:

1. Answer a few questions about your Nurtec denial and medical history
2. We build your case using our database of 4+ million clinical studies, insurer policies, and legal standards
3. We create a fully customized appeal with your personal story + clinical evidence + policy analysis
4. We submit it for you, faxed and mailed directly to your insurer
5. We guide you through escalation if needed

80%+ of Claimable appeals succeed, with most resolved in 10 days or less.

"When my insurance company denied my claim to continue with my medicine, I felt defeated at first... Then I found Claimable. In the end I ended up winning my claim and I couldn't have done it without Claimable. I highly recommend them." — April A.

Appealing with Claimable is just $39.95. No success fees, no hidden costs. Just a simple flat fee. If your migraine medication costs $1,000+ per month, the math is simple.

Start your Nurtec appeal →

Appeal Timelines: How Long Does a Nurtec Appeal Take?

The faster you submit a complete, well-documented appeal, the faster you'll get a decision. While these timelines seem slow, getting your appeal right can speed things up significantly. The average Claimable appeal gets a response in just 10 days.

FAQs

Why was my Nurtec denied if my plan covers it? Having Nurtec on your plan's formulary doesn't mean it's automatically approved. Most plans require prior authorization, and the PA criteria often include step therapy requirements, quantity limits, or documentation thresholds that aren't obvious from your benefits summary. Pfizer reports that 97% of commercial plans cover Nurtec — but "covered" and "approved without a fight" are very different things.

Can I appeal a Nurtec denial myself, or does my doctor have to do it? You can appeal yourself. Patient-initiated appeals often have stronger legal protections than provider appeals, including mandated timelines and the right to external review. You can appeal in addition to your doctor's appeal — they're separate processes.

What if my insurer wants me to try Ubrelvy instead of Nurtec? This is a step therapy requirement. Your appeal should focus on why Nurtec specifically is the right choice. If you need both acute and preventive coverage, Nurtec is the only oral gepant approved for both — that's a strong clinical argument against switching to a drug that only covers one indication.

How many tablets should I be prescribed? For acute use, up to 8 tablets per month. For prevention, approximately 15 tablets per month (75 mg every other day). The maximum is 18 doses in a 30-day period. If your doctor prescribed preventive dosing, make sure the PA was submitted for the preventive indication.

Can I take Nurtec with an injectable CGRP medication like Aimovig? Some insurers will deny this combination, but clinical evidence and AHS guidance support using a CGRP monoclonal antibody for prevention alongside an oral gepant for acute treatment. If you receive a duplicate therapy denial, a detailed clinical rationale from your neurologist is essential.

What's the difference between Nurtec and other CGRP medications? CGRP medications aren't interchangeable. Nurtec is the only oral gepant approved for both acute treatment and prevention of episodic migraine. Ubrelvy and Zavzpret are acute-only. Qulipta is prevention-only. Aimovig, Ajovy, Emgality, and Vyepti are injectable monoclonal antibodies for prevention.

How much does Nurtec cost without insurance? Approximately $1,000+ for an 8-tablet dose pack. Pfizer offers a savings card for commercially insured patients that can reduce the cost to as little as $0/month (with a $7,000 annual cap), and a first-fill program providing one prescription at no cost while benefits are verified.

Is it worth appealing? Yes. The insurance industry counts on patients giving up — fewer than 1% of denials are ever appealed. But when patients do appeal with proper documentation, overturn rates are significant. You've already been prescribed this medication by a doctor who believes you need it. The appeal is your chance to make that case.

Claimable's physician-led team has helped patients recover millions in care access by fighting insurance denials. We're SOC 2 Type II certified and HIPAA compliant. Learn more about how Claimable works →

Related: Why Was My Migraine Treatment Denied? Common Insurance Denial Reasons and How to Fight Back